By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
“I am taking this step with a heavy heart and a sense of responsibility for the university since a sufficient foundation of mutual trust no longer remained with some parts of the university to ensure successful cooperation”, – Simone Fulda
The sad state of affairs of oncology drug discovery
Svante Pääbo, the father of paleogenomics, went funny before his Nobel Prize.
“In October of this year, the scientist who closed the American laboratory, disposed of related assets in the United States, and returned to Shanghai with his wife to start a business, officially opened the mode of “wholeheartedly” returning to his country to start a business.”
The grass root revolution continues, but I’m not on Twitter anymore.
View post to subscribe to site newsletter.
“The 63 papers of Academician Cao Xuetao were questioned on the Internet. After investigation, no fraud, plagiarism and plagiarism were found, but many papers were found to have misuse of pictures, reflecting the lack of a strict laboratory management.”
Swedish prosecutor opened a criminal indictment against Paolo Macchiarini. The scandal surgeon will have to stand court trial for all 3 deadly plastic trachea transplants he performed at Karolinska.
Karin Dahlman-Wright, Karolinska Institute’s former president, then vice-president, now rector’s counsellor was found guilty of research misconduct, again. This time in 4 papers.
And then a Swedish court overturned everything and declared her innocent.
Erick Carreira’s letter to Guido, from 1996. You all saw it probably at some point, and now it’s being discussed again.
Star cancer researcher Pier Paolo Pandolfi left Harvard. The allegations are very serious, but do his new employers in Nevada and Italy mind?
For Better Science